|
bw_start_lo body weight, pre-infection
, dose group: low
46901
|
Female |
10 |
5 |
9 |
10 |
5 |
8 |
2 |
20 |
|
|
10 |
5 |
15 |
10 |
30 |
5 |
|
14 |
|
5 |
9 |
5 |
|
Male |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
bw_start_med body weight, pre-infection
, dose group: medium
46902
|
Female |
12 |
5 |
10 |
10 |
5 |
15 |
9 |
15 |
10 |
5 |
8 |
10 |
110 |
|
55 |
10 |
4 |
9 |
5 |
5 |
6 |
10 |
3 |
Male |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
bw_start_hi body weight, pre-infection
, dose group: high
46903
|
Female |
10 |
5 |
10 |
10 |
15 |
30 |
19 |
20 |
24 |
19 |
3 |
15 |
104 |
|
15 |
15 |
4 |
4 |
10 |
12 |
|
15 |
20 |
Male |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
bw_change_lo change in body weight, post-infection
, dose group: low
46911
|
Female |
10 |
5 |
9 |
10 |
5 |
8 |
2 |
20 |
|
|
10 |
5 |
15 |
10 |
30 |
5 |
|
14 |
|
5 |
9 |
5 |
|
Male |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
bw_change_med change in body weight, post-infection
, dose group: medium
46912
|
Female |
12 |
5 |
10 |
10 |
5 |
15 |
9 |
15 |
10 |
5 |
8 |
10 |
110 |
|
55 |
10 |
4 |
9 |
5 |
5 |
6 |
10 |
3 |
Male |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
bw_change_hi change in body weight, post-infection
, dose group: high
46913
|
Female |
10 |
5 |
10 |
10 |
15 |
30 |
19 |
20 |
24 |
19 |
3 |
15 |
102 |
|
13 |
15 |
4 |
4 |
10 |
12 |
|
15 |
20 |
Male |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
survival_lo survival (days to death, max 30)
, dose group: low
46921
|
Female |
10 |
5 |
9 |
10 |
5 |
8 |
2 |
20 |
|
|
10 |
5 |
15 |
10 |
30 |
5 |
|
14 |
|
5 |
9 |
5 |
|
Male |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
survival_med survival (days to death, max 30)
, dose group: medium
46922
|
Female |
12 |
5 |
10 |
10 |
5 |
15 |
9 |
15 |
10 |
5 |
8 |
10 |
110 |
|
55 |
10 |
4 |
9 |
5 |
5 |
6 |
10 |
3 |
Male |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
survival_hi survival (days to death, max 30)
, dose group: high
46923
|
Female |
10 |
5 |
10 |
10 |
15 |
30 |
19 |
20 |
24 |
19 |
3 |
15 |
104 |
|
15 |
15 |
4 |
4 |
10 |
12 |
|
15 |
20 |
Male |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
resistance_lo susceptibility to viral infection (0=susceptible, 1=resistant)
, dose group: low
46931
|
Female |
10 |
5 |
9 |
10 |
5 |
8 |
2 |
20 |
|
|
10 |
5 |
15 |
10 |
30 |
5 |
|
14 |
|
5 |
9 |
5 |
|
Male |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
resistance_med susceptibility to viral infection (0=susceptible, 1=resistant)
, dose group: medium
46932
|
Female |
12 |
5 |
10 |
10 |
5 |
15 |
9 |
15 |
10 |
5 |
8 |
10 |
110 |
|
55 |
10 |
4 |
9 |
5 |
5 |
6 |
10 |
3 |
Male |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
resistance_hi susceptibility to viral infection (0=susceptible, 1=resistant)
, dose group: high
46933
|
Female |
10 |
5 |
10 |
10 |
15 |
30 |
19 |
20 |
24 |
19 |
3 |
15 |
104 |
|
15 |
15 |
4 |
4 |
10 |
12 |
|
15 |
20 |
Male |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|